Leah Backhus, MD, joins Dr. Gillaspie to explore key takeaways from WCLC, including how precision data, surgical restraint, and breakthrough immunotherapy are transforming care.

In this episode, Dr. Gillaspie speaks with Paula Ugalde, MD, to examine findings from ELCC, including restaging in the neoadjuvant era, redefining resectability, AI in multidisciplinary precision, and the de-escalation debate.

Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

Host Erin Gillaspie, MD, sits down with Brendon Stiles, MD, to discuss insights from ASCO, including perioperative immunotherapy, CheckMate 816, and expanding surgical boundaries.

The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.

The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress.

Listen now to explore where mesothelioma research is headed and what it means for patient care.

In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.

The latest episode of Thinking Thoracic takes on a topic that’s on everyone’s minds: finances. Host Erin Gillaspie, MD, sits down with Lawrence Greiten, MD, and Josh Daily, MD, both from Arkansas Children’s Hospital, to discuss their recent paper examining financial decision-making in cardiothoracic surgery. From training pathways to compensation survey data, the conversation highlights how earnings and financial trade-offs shape career choices and negotiations. Tune in today.

This latest episode of Thinking Thoracic, an STS podcast, features host Erin Gillaspie, MD, in conversation with Jonathan Spicer, MD, a leading thoracic oncologist and clinical trial investigator. The two dive into the landmark CheckMate 816 trial, which helped usher in a new era for immunotherapy in lung cancer treatment. Dr. Spicer shares insights on trial design, clinical outcomes, and what these findings mean for the future of thoracic surgery and oncology. Listen today.

Don’t miss the latest Thinking Thoracic episode as host Erin Gillaspie, MD, is joined by Stephanie Worrell, MD, associate professor, University of Arizona, and thoracic surgeon, Banner Health, for a lively and insightful post-ASCO discussion. Together, they unpack the significance of the CheckMate 577 and Matterhorn trials, and explore what these groundbreaking studies mean for the future of esophageal and gastroesophageal junction cancer care.

In this episode of Thinking Thoracic, Dr. Elliott Servais, Lahey Hospital & Medical Center, joins host Dr. Erin Gillaspie to share how he developed a robotic 1st rib resection program. Recognizing an unmet need at his institution, he seized the opportunity to build a dedicated program. The result? A growing referral network and a newfound enthusiasm for a procedure he once dreaded.